Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
348 hedge funds and large institutions have $6.41B invested in Exact Sciences in 2018 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 95 increasing their positions, 127 reducing their positions, and 48 closing their positions.
65% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 48
45% more capital invested
Capital invested by funds: $4.41B → $6.41B (+$2B)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
9% more funds holding
Funds holding: 319 → 348 (+29)
2.81% less ownership
Funds ownership: 90.54% → 87.73% (-2.8%)
25% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 127
68% less call options, than puts
Call options by funds: $122M | Put options by funds: $383M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$353M |
| 2 |
Millennium Management
New York
|
+$50.5M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$47.8M |
| 4 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
+$42.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$31.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$132M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$129M |
| 3 |
FAM
Fred Alger Management
New York
|
-$80.4M |
| 4 |
State Street
Boston,
Massachusetts
|
-$64.7M |
| 5 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$52.3M |
EXAS Hedge Fund Activity: Q2 2018 in Review
348 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2018, worth a combined $6.41B — up 45% from $4.41B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new EXAS positions and 48 closed out — a net gain of 31 holders — while 95 added to existing stakes and 127 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $353M. The largest seller was BlackRock, cutting an estimated $132M.
- 348 institutional investors held Exact Sciences (EXAS) as of Q2 2018, up from 319 in Q1 2018.
- Funds reported $6.41B of Exact Sciences stock for Q2 2018, up 45% quarter-over-quarter.
- 79 funds opened new Exact Sciences positions in Q2 2018 and 48 closed out, a net change of +31 holders.
- The largest Exact Sciences buyer in Q2 2018 was T. Rowe Price Associates, an estimated $353M added.
- The largest Exact Sciences seller in Q2 2018 was BlackRock, an estimated $132M sold.
Based on aggregated 13F filings for Q2 2018.